<DOC>
	<DOCNO>NCT01389557</DOCNO>
	<brief_summary>Artemisinin-based combination therapy ( ACT ) know controversial stop malaria transmission . The addition primaquine ( PQ ) - drug commercially available kill mature transmission stage - treatment might necessary eliminate stage . A study conduct evaluate efficacy dihydroartemisinin-piperaquine ( DHP ) regimens PQ malaria transmission community wide level Lempasing , Lampung , Sumatra .</brief_summary>
	<brief_title>Impact Dihydroartemisinin-piperaquine Plus Primaquine Malaria Transmission Lampung Province , Sumatra</brief_title>
	<detailed_description>A mass screen baseline survey enable description malaria prevalence ( P. falciparum P. vivax ) . Malaria infect asymptomatic ( mass screen ) symptomatic ( malaria infect people attend health center ) people enrol study . Enrolled malaria infect subject treat DHP PQ accord treatment regimen . The community mass screen malaria infection every 3 month incidence cohort screen every month infection . The 3 aim look malaria antibody , haemoglobin level incidence malaria drug intervention .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Dihydroartemisinin</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Primaquine</mesh_term>
	<mesh_term>Piperaquine</mesh_term>
	<criteria>All individual reside Lempasing village , kecamatan Hanura , Lampung province study period Individuals severe chronic disease ( liver , kidney ) , infant pregnant breastfeed woman Individuals refuse sign inform consent exclude . normal glucose6phosphate dehydrogenase enzyme level base qualitative test ( Trinity BiotechÂ® 203 , USA ) willingness sign informedconsent form</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>malaria</keyword>
	<keyword>DHP</keyword>
	<keyword>PQ</keyword>
	<keyword>MST</keyword>
</DOC>